Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study

INTRODUCTION: To assess the efficacy and safety of the interleukin-1 receptor (IL-1R) inhibitor anakinra in adult patients with refractory Still's disease. METHODS: Twenty-five patients (13 males and 12 females, median age 32 years, median disease duration seven months) with Still's diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Laskari, Katerina, Tzioufas, Athanasios G, Moutsopoulos, Haralampos M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218906/
https://www.ncbi.nlm.nih.gov/pubmed/21682863
http://dx.doi.org/10.1186/ar3366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218906/
https://www.ncbi.nlm.nih.gov/pubmed/21682863
http://dx.doi.org/10.1186/ar3366

Ejemplares similares